RxDoctor Payments Data

Jose Chavez, DO

Interventional Pain Medicine · Scottsdale, AZNPI 1467730135

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,646 of the $6,626 with a category attached, or 85.2%. 15 manufacturers reported payments, led by Abbott at 54.5% of the total. Reporting peaked in 2019 at $3,142 and has fallen 93.0% since, to $220 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in AZ, where the typical reported total is $8,993.

$6,626in general payments, 2019–2025

Across 228 payments — averaging $29.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • Nevro Corp.$2K
  • Boston Scientific$228
  • Nalu Medical, Inc.$187
  • Vertos Medical, Inc.$165
  • Stryker$135
  • plus $591 from 9 others

What the payments were for

  • Travel & lodging$98015%
  • Food & beverage$5,64685%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,626 in reported general payments places this provider in the 40th percentile of 64 interventional pain medicine providers in Arizona.

See all interventional pain medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$146,224
Medicare patients
148
Services billed
1,949

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl33$20,834
Xtampza ErOxycodone Myristate16$7,798
Oxycodone Hcl298$5,500
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen160$4,423
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen139$4,348
Morphine Sulfate ErMorphine Sulfate189$3,922
Lidocaine19$3,036
Gabapentin80$1,057
Morphine Sulfate34$1,049
Tizanidine Hcl77$916
Methocarbamol45$699
Tramadol Hcl61$528
Amitriptyline Hcl34$526
Diclofenac Sodium13$394
Pregabalin43$335

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →